David Walton
Corporate Officer/Principal chez LUMIRADX LIMITED
Fortune : 56 834 $ au 31/12/2023
Profil
David Walton is currently the Chief Commercial Officer at LumiraDx Ltd.
(Cayman Islands) and LumiraDX Ltd.
He previously worked as the International Director-Consumer Business Unit at Unipath Ltd., Director at Abbott Diagnostics Korea, Inc., and President-Asia Pacific at Alere, Inc. He also served as Vice President-International Business at Unilever Plc.
Dr. Walton received his undergraduate degree from The University of Manchester and his doctorate from the University of London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LUMIRADX LIMITED
0,43% | 31/12/2022 | 902 122 ( 0,43% ) | 56 834 $ | 31/12/2023 |
LUMIRADX LIMITED
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/12/2023 |
Postes actifs de David Walton
| Sociétés | Poste | Début |
|---|---|---|
| LUMIRADX LIMITED | Corporate Officer/Principal | 01/08/2014 |
LumiraDx Ltd. (Cayman Islands)
 LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Corporate Officer/Principal | 01/08/2014 |
Anciens postes connus de David Walton
| Sociétés | Poste | Fin |
|---|---|---|
| ALERE INC | Corporate Officer/Principal | 01/09/2014 |
| UNILEVER PLC | Corporate Officer/Principal | 01/01/2007 |
Abbott Diagnostics Korea, Inc.
 Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Director/Board Member | - |
Unipath Ltd.
 Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Corporate Officer/Principal | - |
Formation de David Walton
| The University of Manchester | Undergraduate Degree |
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNILEVER PLC | Consumer Non-Durables |
| LUMIRADX LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Health Technology |
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Health Technology |
